Compare HELE & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELE | OCGN |
|---|---|---|
| Founded | 1968 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 483.6M | 387.3M |
| IPO Year | N/A | N/A |
| Metric | HELE | OCGN |
|---|---|---|
| Price | $19.05 | $1.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.00 | $7.00 |
| AVG Volume (30 Days) | 1.1M | ★ 5.7M |
| Earning Date | 01-08-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,802,156,000.00 | $5,370,000.00 |
| Revenue This Year | N/A | $35.88 |
| Revenue Next Year | $0.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.26 |
| 52 Week Low | $17.01 | $0.52 |
| 52 Week High | $69.05 | $1.96 |
| Indicator | HELE | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 58.56 |
| Support Level | $18.26 | $1.58 |
| Resistance Level | $20.00 | $1.96 |
| Average True Range (ATR) | 1.39 | 0.15 |
| MACD | -0.23 | 0.02 |
| Stochastic Oscillator | 22.72 | 60.16 |
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").